Ginseng is renowned in Asian medicine for its health-giving properties — but a prominent South Korean activist investor thinks his top target would help shareholders by giving it up.
Lee Sang-hyun, the chief of South Korean activist fund Flashlight Capital Partners, has been pushing for the country’s largest tobacco producer KT&G to spin off its ginseng unit and appoint two renowned independent outside directors. He thinks ginseng can be better marketed and attract more long-term…
Read the full article here